Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial | Zendy

Kelly E. Dooley | Zendy; Richard Kaplan | Zendy; Noluthando Mwelase | Zendy; Beatriz Grinsztejn | Zendy; Eduardo Ticona | Zendy; Marcus Lacerda | Zendy; Omar Sued | Zendy; Elena Belonosova | Zendy; Mounir AitKhaled | Zendy; Konstantinos Angelis | Zendy; Dannae Brown | Zendy; Rajendra Singh | Zendy; Christine L. Talarico | Zendy; Allan R. Tenorio | Zendy; Michael R. Keegan | Zendy; Michael Aboud | Zendy; Kaplan Richard | Zendy; Mwelase Noluthando | Zendy; Ticona Chavez Eduardo | Zendy; Lacerda Marcus | Zendy; Ait-Khaled Mounir | Zendy; A. Konstantinos | Zendy; Brown Dannae | Zendy; Singh Rajendra | Zendy; Lupo Sergio | Zendy; Pedro Cahn | Zendy; Norma Porteiro | Zendy; Daniel Lopardo Gustavo | Zendy; Riegel Santos Breno | Zendy; Madruga Jose | Zendy; Roberto Alves Carlos | Zendy; Patricia Quintero Perez Nora | Zendy; Rodriguez Noriega Eduardo | Zendy; P. Alma | Zendy; Perez Patrigeon Santiago | Zendy; Mosqueda-Gómez Juan-Luis | Zendy; Paredes Paredes Mercedes | Zendy; R Boccaccini Aldo | Zendy; Mac Rae John | Zendy; Casapia Wilfredo | Zendy; Sanchez Vergaray Eduardo | Zendy; Sultanov Lenar | Zendy; Ivanova Elvira | Zendy; Yakovlev Alexey | Zendy; Panteleev Alexander | Zendy; Dawson Rodney | Zendy; Latiff H Gulam | Zendy; Mohapi Lerato | Zendy; Taljaard Jantjie | Zendy; Jurgens Lombaard Johannes | Zendy; Khan Mohammed | Zendy; Ebrahim Variava | Zendy; Chetchotisakd Ploenchan | Zendy; Kiertiburanakul Sasisopin | Zendy; Anchalee Avihingsa | Zendy

Open Access

Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial

Author(s) -

Kelly E. Dooley,

Richard Kaplan,

Noluthando Mwelase,

Beatriz Grinsztejn,

Eduardo Ticona,

Marcus Lacerda,

Omar Sued,

Elena Belonosova,

Mounir AitKhaled,

Konstantinos Angelis,

Dannae Brown,

Rajendra Singh,

Christine L. Talarico,

Allan R. Tenorio,

Michael R. Keegan,

Michael Aboud,

Kaplan Richard,

Mwelase Noluthando,

Ticona Chavez Eduardo,

Lacerda Marcus,

Ait-Khaled Mounir,

A. Konstantinos,

Brown Dannae,

Singh Rajendra,

Lupo Sergio,

Pedro Cahn,

Norma Porteiro,

Daniel Lopardo Gustavo,

Riegel Santos Breno,

Madruga Jose,

Roberto Alves Carlos,

Patricia Quintero Perez Nora,

Rodriguez Noriega Eduardo,

P. Alma,

Perez Patrigeon Santiago,

Mosqueda-Gómez Juan-Luis,

Paredes Paredes Mercedes,

R Boccaccini Aldo,

Mac Rae John,

Casapia Wilfredo,

Sanchez Vergaray Eduardo,

Sultanov Lenar,

Ivanova Elvira,

Yakovlev Alexey,

Panteleev Alexander,

Dawson Rodney,

Latiff H Gulam,

Mohapi Lerato,

Taljaard Jantjie,

Jurgens Lombaard Johannes,

Khan Mohammed,

Ebrahim Variava,

Chetchotisakd Ploenchan,

Kiertiburanakul Sasisopin,

Anchalee Avihingsa

Publication year - 2019

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciz256

Subject(s) - dolutegravir , medicine , human immunodeficiency virus (hiv) , antiretroviral therapy , open label , tuberculosis , randomized controlled trial , virology , sida , clinical trial , viral disease , viral load , pathology

The concurrent treatment of tuberculosis and human immunodeficiency virus (HIV) is challenging, owing to drug interactions, overlapping toxicities, and immune reconstitution inflammatory syndrome (IRIS). The efficacy and safety of dolutegravir (DTG) were assessed in adults with HIV and drug-susceptible tuberculosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research